Literature DB >> 3882655

Therapeutic potential of high renal levels of aminoglycosides in pyelonephritis.

M G Bergeron.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882655     DOI: 10.1093/jac/15.1.4

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis.

Authors:  T Sandberg; G Englund; K Lincoln; L G Nilsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

3.  Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.

Authors:  P Van der Auwera; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

4.  Effect of Enterococcus faecalis pyelonephritis on the intracortical accumulation kinetics of gentamicin in rats.

Authors:  M Jullien; G Thériault; M G Bergeron; D Beauchamp
Journal:  Can J Infect Dis       Date:  1990

5.  Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children.

Authors:  A Viganò; N Principi; L Brivio; P Tommasi; P Stasi; A D Villa
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

6.  Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis.

Authors:  P Auclair; C Lessard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.